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Ibuprofen is a poorly water-soluble drug with analgesic, antipyretic 
and anti-inflammatory effects. Self-Nano Emulsifying Drug Delivery System 
(SNEDDS) formulation is a solution to improve the solubility and 
bioavailability of ibuprofen. This research purposed to perform a 
formulation, characterization, and stability studies of ibuprofen-loaded Self-
Nano Emulsifying Drug Delivery System (SNEDDS). Screening of ibuprofen 
SNEDDS was prepared by ternary diagrams for the chosen co-surfactants, 
surfactants, and oil. The following was characterizations of droplet size, zeta 
potential, and clarity. The solubility test for the determination of co-
surfactant, surfactant, and oil obtained Propylene glycol monocaprylate 
(Capryol-90), Polysorbate 20 (Tween 20) and PEG 400. The screening of 
SNEDDS showed nine formulas (compositions) in the range concentration 
of Propylene glycol monocaprylate (1-3mL), Polysorbate 20 (4-8mL),             
and PEG 400 (1-3mL). The composition of Propylene glycol monocaprylate 
(1-2mL), Polysorbate 20 (5-8mL) and PEG 400 (1-3mL) passed the 
thermodynamic stability test. The test of robustness to dilution and stability 
study indicated that the formula with Propylene glycol monocaprylate, 
Polysorbate 20 and PEG 400 with the ratio of 1: 8: 1 and 1: 7: 2 was more 
stable. In conclusion, the stable ibuprofen SNEDDS could be prepared with 
Propylene glycol monocaprylate, Polysorbate 20, and PEG 400. 




Well-known as an antipyretic, analgesic, and 
non-steroidal drug for anti-inflammation, 
ibuprofen is useful for fever, its symptoms, and 
rheumatoid arthritis and osteoarthritis signs. Due 
to its low solubility and high permeability, 
ibuprofen is categorized as BCS class II (Álvarez et 
al., 2011; Deng et al., 2018). The solubility and 
bioavailability of ibuprofen should be increased to 
improve therapy effectiveness by developing the 
drug delivery system. Among the approaches to 
enhance dissolution characteristics of water-
insoluble drugs are cyclodextrin complexation, 
particle-size reduction, crystal modification, and 
self-emulsification (Syukri et al., 2015). Meanwhile, 
self-micro emulsifying, self-emulsifying, and 
liposomes are among the most widely-developed 
methods to improve solubility and bioavailability 
of orally-given drugs in lipid-based formulations 
(Shafiq-un-Nabi et al., 2007).  
Some common permeability enhancers 
include lipid-based excipients, such as fatty acids 
and glycerides as well as ionic and non-ionic 
surfactants. Such excipients can increase 
membrane fluidity or open tight junctions (Kuentz, 
2012). The entry of some highly lipophilic drugs 
and long-chain triglycerides (TG) into the portal 
circulation, however, is reduced depending on their 
entry into the lymphatic circulation. Hence, 
lymphatic- rather than portal-transported drugs 
can avoid the first-pass metabolism by the liver that 
in turn enhances the concentration of drug in 
lymph ducts and nodes where therapeutic drug 
action exists (Yáñez, et al., 2011). 
Self-Nano Emulsifying Drug Delivery System 
(SNEDDS) becomes one of these simplified 
approaches to enhance drug solubility and 
dissolution. In SNEDDS, a thermodynamically 
stable oil-in-water emulsion is formed 
spontaneously when an isotropic mixture of drug, 
oil, surfactant, and co-surfactant enters the 
aqueous phase under gentle agitation conditions 
resembling those to be encountered in the GI tract 
(Dash,  et  al.,  2015a;   Sriamornsak,  et   al.,  2015). 
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Studies show that SNEDDS improve the solubility, 
dissolution, and bioavailability of drugs with poor 
solubility in water, including lovastatin (Yadava, et 
al., 2015), glipizide (Agrawal, et al., 2015), 
nisoldipine (Nekkanti et al., 2016), and anti-cancer 
genistein (Shehata, et al., 2016). The SNEDDS of 
nystatin was found to be able to improve 
dissolution as well as oral antifungal efficacy 
(Kassem et al., 2016). Another study revealed that, 
compared to the plain formulation, the 
andrographolide isolated from Andrographis 
paniculata plant in the form of SNEDDS formulation 
provided better bioavailability and dissolution 
(Syukri et al., 2018).  
Ibuprofen is currently marketed 
commercially in tablet and capsule dosage forms. 
Both forms demonstrate low, erratic oral 
bioavailability because of their poor solubility             
and dissolution (Shahba et al., 2012). Ibuprofen can 
be formulated into SNEDDS to enhance absorption 
as well as avoid the first-pass metabolism.               
This study aimed to prepare, characterize, and 
examine the stability of ibuprofen in SNEDDS 
formulation. 
 
MATERIALS AND METHODS 
Materials 
Ibuprofen was bought from Cross Chem. 
Polysorbate 80 (Tween 80), Polysorbate 20 
(Tween 20), oleic acid, olive oil, polyethylene glycol 
(PEG) 400, and propylene glycol were obtained 
from Brataco Indonesia Ltd. Labrasol, Propylene 
glycol monocaprylate (Capryol 90), and Labrafil 
M1944CS were gifted by Gattefose (France), 
Cremophor RH 40 from BASF (Indonesia), and 
Myritol 318 from Phapros Indonesia Ltd. 
 
Solubility test to select oil, surfactant, and co-
surfactant  
The shake-flask method was used to 
determine ibuprofen solubility in different oil, 
surfactant, and co-surfactant concentrations. Extra 
ibuprofen was added into each vehicle and mixed 
in the vortex (Heidolph Reax Top, Germany) for 
10min followed by a 48-h mixture shaking at 37ᵒC 
in a shaking water bath with thermostatically-
controlled condition from Memmert WNE 45, 
Germany. After reaching stability for 24h, the 
mixture was put in centrifugation from Hettich 
Mikro 22R, Germany at 6000 rpm for 10min. The 
supernatant was collected, and concentration was 
calculated employing UV-Vis spectrophotometer 
(Shimadzu UV 1800, Japan) at a wavelength of 
223nm. 
 
Construction of ternary diagrams 
The selected co-surfactants, surfactants, and 
oils obtained from the solubility study were plotted 
in a ternary diagram without incorporation of the 
drug; one side of the triangle represented each 
selection for identification of the region of self-
nano emulsifying (Kassem et al., 2016). A set of oil, 
surfactant, and co-surfactant mixtures was 
provided with composition of 1-5; 2-8; and 1-3mL, 
respectively. The composition of oil, surfactant, and 
co-surfactant for ternary phase diagrams (Table I).  
Table I. Composition of oil, surfactant, and co-surfactant for construction of ternary diagrams 
 
Composition Oil  (mL) Surfactant (mL) Co-surfactant (mL) 
C1 1 8 1 
C2 1 7 2 
C3 1 6 3 
C4 2 7 1 
C5 2 6 2 
C6 2 5 3 
C7 3 6 1 
C8 3 5 2 
C9 3 4 3 
C10 4 5 1 
C11 4 4 2 
C12 4 3 3 
C13 5 4 1 
C14 5 3 2 
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The assessment was conducted for the 
nanoemulsion formed after each formulation 
(compositions) was given 100-fold dilution in 
aquabidest. The clarity, zeta potential, and droplet 
size of resulted dispersions were then measured 
using particle size analyzer from Horiba SZ 100; 
Japan and UV-Vis spectrophotometer from 
Shimadzu UV 1800; Japan at a wavelength of 
650nm. Dispersions remained up to standard as 
long as the droplet size was not more than 200nm. 
Then, the ternary phase diagrams of co-surfactant, 
surfactant, and oil were plotted. 
 
Preparation of ibuprofen-loaded SNEDDS  
As much as 5mL mixture of oil, surfactant, 
and co-surfactant was used to dissolve               
Ibuprofen (200mg) for preparation of SNEDDS 
formulation. Dissolution was conducted in 
ultrasonic homogenizer (model 300 V/T, USA) for 
solubilization to obtain clear solution. The mixture 
was then stored at ambient temperature for future 
use. 
  
Ibuprofen-loaded SNEDDS characterization 
Percentage of clarity (transmittance) studies 
Purified water was used to dilute the 
ibuprofen-loaded SNEDDS formulations 100 times. 
The clarity (%) was determined through UV–Vis 
spectrophotometer from Shimadzu UV 1800, Japan 
at a wavelength of 650nm (Nagi et al., 2017), and 
the blank was purified water.   
 
Zeta potential and droplet size 
The zeta potential and droplet size of 
SNEDDS were measured by particle size analyzer 
from Horiba SZ 100; Japan followed by dilution of 
SNEDDS samples in purified water for 100 times.  
 
Thermodynamic stability studies 
Centrifugation study 
Centrifugation of the formulations was 
conducted at 5000rpm for 30min followed by 
visual observation to confirm instability, including 
cracking, phase separation, drug precipitation, or 
creaming. The formulations without any signs of 
weakness were selected for the heating-cooling 
test. 
 
Heating and cooling cycle 
The heating and cooling cycle was done          
in three repetitions at a temperature range of       
4°C-45°C and a minimum of 48-hour storage. The 
period was conducted in one repetition for 8h at a 
temperature of 4°C and 8h at a temperature of 
45°C. The formulations that survived such 
condition without signs of creaming and phase 
separation were selected for the freezing and 
thawing cycle.  
 
Freezing and thawing cycle  
The freeze and thaw test was conducted                  
3 times between −20°C and +25°C temperature 
with a minimum of 48 hours storage duration.             
The period was held in one repetition for 8h at a 
temperature of 4°C and 8h at a temperature of 
45°C. Further analysis was performed for                    
the formulations surviving such thermodynamic 
stress test (Agrawal et al., 2015; Kassem et al., 
2016). 
Robustness to dilution  
 Robustness to dilution significantly           
affects the phase separation of a spontaneously 
emulsifying system. A system with spontaneous 
emulsification attempts to emulate in vivo 
conditions where formulations dilute g radually. 
Dilution of ibuprofen-loaded SNEDDS in purified 
water was conducted for 25, 50, 100, and 250 
times. The droplet size was then evaluated to select 
the compositions with consistent droplet size after 
dilution in different dispersion media to proceed 
with in-vitro assay (Balakumar, et al., 2013; 
Elnaggar et al., 2009). Milky-like composition was 
let rest while the transparent one was observed to 
determine the droplet size.  
 
Stability study 
To assess the accelerated stability, the 
optimized ibuprofen-loaded SNEDDS was stored in 
sealed amber glass vials for four weeks at a high 
temperature (40ᵒ±2ᵒC) and relative humidity 
(75±5%). The changes over time in the physical 
characteristics, such as drug droplet size and 
clarity, were monitored to evaluate the physical 
stability of the optimized composition. The one-
way ANOVA was used for comparing droplet size 
changes every week. 
 
RESULTS AND DISCUSSION 
Solubility test to select oil, surfactant, and co-
surfactant  
Drug solubility in vehicles is essential to 
determine formulation stability because it is 
commonly found that many formulations 
precipitate before experiencing in situ 
solubilization. A combination of oil, surfactant, and 
co-surfactant produce a self-emulsifying mixture. 
Such mixture should provide a transparent and 
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isotropic liquid at a room temperature with fine 
solubility to integrate a dose of drug in a minimum 
volume of mixture (Kassem et al., 2016) 
Oils, surfactants, and co-surfactants for 
SNEDDS formulations are selected according to the 
highest solubility of ibuprofen in each of them. 
Besides, the selection is also based on the ability of 
the mixtures to form nanoemulsion when diluted 
100 times with aquabidest. The results of ibuprofen 
solubility test in different sets of oil, surfactant, and 
co-surfactant (Table II). 
Table II indicates that the oil phase, 
Propylene glycol monocaprylate, had the best 
solubilizing capacity (64.53±0.19), and for the 
same reason Polysorbate 20 (97.71±0.16) and PEG 
400 (35.02±0.08) were chosen as the best 
surfactant and co-surfactant. 
 
Construction of ternary diagrams 
The self-nano emulsifying area is 
determined using a ternary phase diagram, which 
is also utilized to assess oil, surfactant, and co-
surfactant concentrations for stable SNEDDS. 
Figure 1 illustrated the ternary phase diagram of 
formulations with a carrier consisting of Propylene 
glycol monocaprylate, Polysorbate 20, and PEG 
400. 
The shaded/dark area marks the regions of 
nanoemulsion and macroemulsion. The formulation 
with 1-3mL of Propylene glycol monocaprylate 
(oil), 4-8mL of Polysorbate 20 (surfactant), and              
1-3mL of PEG 400 (co-surfactant) has produced 
transparent nanoemulsion without sedimentation. 
In such region, spontaneous self-emulsification 
results in dispersion that is thermodynamically 
stable. Meanwhile, the composition having 4-5mL 
Propylene glycol monocaprylate produces milky-
like or crude macroemulsion (Kassem et al., 2016; 
Parmar et al., 2011) in which no self-emulsification 
occurs. 
 
Preparation of ibuprofen-loaded SNEDDS  
The inexistence of precipitation and phase 
separation for 48h indicates that ibuprofen 
Table II. Solubility test of ibuprofen in varied oils, surfactants, and co-surfactants (n=3) 
 
Vehicle Material Solubility (mg/mL) 
Oil 
Propylene glycol monocaprylate 64.53±0.19 
Myriol 318 13.33±0.01 
Oleic acid 60.67±0.09 
Olive oil 9.53±0.01 
Surfactant 
Labrasol 83.18±0.74 
Labrafil M1944CS 26.18±0.02 
Polysorbate 20 97.71±0.16 
Polysorbate 80 73.10±0.16 
Cremophor RH 40 36.55±0.14 
Co-surfactant 
PEG 400 35.02±0.08 




Figure 1. Ternary diagram of ibuprofen showing the region of o/w nanoemulsion in Propylene glycol 
monocaprylate, Polysorbate 20 and PEG 400 as the oil, surfactant and co-surfactant 
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dissolves in SNEDDS. In this study, ibuprofen was 
stable in the SNEDDS formulation with 
200mg/5mL drug loading. The results of the 
characterization by calculating the droplet size, 
clarity, and zeta potential (Table III). 
 
Droplet size 
Range of droplet size of C1 to C9 is between 
12.00±2.60nm and 70.53±3.43nm. C1 to C9 are 
defined as nanoemulsion because they form a clear 
dispersion, and since C10 to C15 have a 
milky/cloudy appearance, they are categorized as 
macroemulsion (Table III). Macroemulsion (C10 to 
C15) with the larger droplet size was not detected 
the droplet size using particle size analyzer (Horiba 
SZ 100) because the equipment only covers the 
droplet size less than 1000nm. Nanoemulsion size 
has a droplet size of less than 200nm (Balakumar, 
et al., 2013). Oil phase in high concentration will 
produce a large droplet size.  
Meanwhile, a large number of cases indicate 
that increasing surfactant concentration will 
decrease droplet size because surfactant molecule 
localization on the interface of oil-water will 
stabilize oil droplets. High surfactant concentration 
will improve the penetration of water into oil 
droplets that lead to the breakdown of oil droplets 
and formation of larger droplets (Balakumar, et al., 
2013). Small co-surfactant molecules will enhance 
surfactant function in emulsification as they 
penetrate the film of surfactant on the interface of 
oil-water, and small droplet size will reduce 
interfacial tension and improve the spontaneous 
process of emulsification. Since the free energy 
required to produce tiny droplet size in a system 
with self-emulsification is lacking, oil 
nanoemulsion will be spontaneously formed in 
water (Heshmati, et al., 2018).   
 
Clarity 
Nanoemulsion is a water-oil-surfactant 
system, which forms a complete mixture that is 
optically isotropic and a solution that is 
thermodynamically stable. Clarity is measured in a 
clarity test to maintain the isotropic range. In such 
an analysis, the dispersion-system transparent 
level will be obtained from water-solution 
dispersion absorbance at 650nm wavelength. 
Table 3 showed Composition 1 (C1) to 9 (C9) have 
clear dispersion with almost 100% clarity, 
indicating fulfilment of the nanoemulsion 
requirement.  
On the other hand, C10 to C15 produced a 
milky-like solution with a clarity value of less than 
34%. Compositions with less clarity have a more 
significant droplet size and result in milky-like 
macroemulsion. The data showed that aqueous 
dispersion having low transparency is usually 
cloudy, and globules of oil have larger dispersion. 
Nanoemulsion clarity indicates self-emulsification 
efficacy by identifying dispersion stability in a 
reproducible or short period. 
Table III. Droplet size, zeta potential, clarity, and description of ibuprofen-loaded SNEDDS as an effect of 
various oil, surfactant and co-surfactant concentrations (n=3) 
 
Composi-tion Droplet size (nm) Zeta potential (mV) Clarity (%) Description 
C1 12.63±1.68 -24.37±0.29 99.98±0.01 Transparent 
C2 12.00± 2.60 -37.37±0.64 99.83±0.01 Transparent 
C3 15.20±1.70 -24.55±0.29 99.48±0.04 Transparent 
C4 15.00±0.10 -31.00±0.52 99.98±0.01 Transparent 
C5 20.97±1.72 -41.53±0.58 99.86±0.01 Transparent 
C6 15.76±1.58 -34.83±0.68 100.00±0.00 Transparent 
C7 70.53±3.43 -22.03±0.55 100.00±0.00 Transparent 
C8 41.33±3.23 -18.73±0.51 99.71±0.02 Transparent 
C9 47.60±1.73 -37.90±0.61 99.41±0.01 Transparent 
C10 321.67±12.00 -17.40±0.36 33.16±0.02 Cloudy 
C11 NA -30.40±0.17 33.67±0.01 Cloudy 
C12 NA -36.10±0.00 26.77±0.02 Cloudy 
C13 498.70±19.41 -46.97±0.29 13.12±0.00 Cloudy 
C14 NA -63.33±0.40 20.29 ±0.01 Cloudy 
C15 NA -27.20±0.35 16.77±0.11 Cloudy 
 
NA: Not Available (Droplet size was undetected 
Formulation, Characterization and Stability of Ibuprofen-Loaded 
110   Volume 30 Issue 2 (2019) 
Zeta potential 
A high value of zeta potential has better 
stability since there is resistance to aggregation of 
the formulation. Zeta potential of less than -30mV 
and more than +30mV is generally appropriate for 
the stability of a system (Dash, et al., 2015b).                      
The nanoemulsion area of C1, C3, C7 and                               
C8 produces a zeta potential of more than -30mV           
(-24.37±0.2, -24.55±0.29, -22.03±0.55, and -
18.73±0.51mV, correspondingly), whereas the 
others result in lower than -30mV zeta potential 
(Table III). It means C1, C3, C7 and C8 fail to meet 
the criteria of zeta potential value for a system 
stability. A negative value of zeta potential 
indicates the existence of free fatty acid, surfactant, 
and co-surfactant in the formulation. It also shows 
the considerable force of repulsion between droplets 
to prevent aggregation (Syukri et al., 2018).  
 
Thermodynamic stability test 
Kinetic stability is crucial for differentiating 
nanoemulsion from the emulsion, showing the 
systems’ thermodynamic stability. Nanoemulsion 
system of SNEDDS is formed following in situ 
solubilization, and creaming, cracking, or 
precipitation can be avoided when stability is 
achieved (Senapati, et al., 2016). For formulations 
C1 to C9, the study of thermodynamic stability 
performed include heating and cooling cycle; 
centrifugation; and freezing and thawing cycle, and 
then the results (Table IV).  
C1 to C6 have no signs of phase separation, 
turbidity, or drug precipitation (Table IV). 
Therefore, they are eligible for robustness to 
dilution test. C7, C8 and C9 did not show a good 
thermodynamically stability test because these 
formulae contain a larger of oil compositions. 
Usually, a larger of the oil composition the droplet 
size the larger. These conditions tend to cause to 
the instability system. 
 
Robustness to dilution 
To emulate an in vivo state, SNEDDS 
compositions are diluted for 25, 50, 100, and 250 
times in media. After the dilution process, emulsion 
uniformity in SNEDDS compositions should remain 
(Elnaggar et al., 2009). Robustness to dilution test 
guarantees SNEDDS emulsion uniformity in 
various frequencies of dilution (Table V). 
Ibuprofen-loaded SNEDDS dilution is conducted 
25-, 50-, 100-, and 250-fold using aquabidest, and 
droplet size is evaluated.  
Table IV. Thermodynamic stability studies of ibuprofen-loaded SNEDDS as an effect of various oil, 
surfactant, and co-surfactant concentrations (n=3) 
 
Composition Centrifugation Heating and cooling cycle Freezing and thawing cycle 
C1 Allowed Allowed Allowed 
C2 Allowed Allowed Allowed 
C3 Allowed Allowed Allowed 
C4 Allowed Allowed Allowed 
C5 Allowed Allowed Allowed 
C6 Allowed Allowed Allowed 
C7 Not Allowed Not Allowed Not Allowed 
C8 Not Allowed Not Allowed Not Allowed 
C9 Not Allowed Not Allowed Not Allowed 
 
Table V. Robustness to dilution studies of ibuprofen-loaded SNEDDS (n=3) 
 
Composition 
Droplet size (nm) 
1:25 1:50 1:100 1:250 
C1 11.30±0.17 11.00±0.62 12.63±1.68 10,50±0.40 
C2 11.43±0.21 13.43±2.06 12.00±2.60 10.47±1.16 
C3 11.60 ±0.27 12.13±0.84 15.20±1.70 23.93±1.72 
C4 251.93±5.85 310.80±8.25 15.00±0.10 65.17±2.21 
C5 332.10±6.07 268.13±5.79 20.97±1.72 53.43±1.10 
C6 NA NA 15.76±1.58 46.50±5.60 
 
NA: Not Available (Droplet size was undetected) 
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C1 and C2 with Propylene glycol 
monocaprylate, Polysorbate 20, and PEG 400 at a 
ratio of 1: 8: 1 and 1: 7: 2, correspondingly, become 
the most stable compositions since, after dilution, 
they have a steady droplet size and are then eligible 
for accelerated stability test (Table V). A regular 
droplet size after dilutions shows the possible 
uniformity of in vivo drug release. Thus, the 
preparations might have the capability of 
anticipating gradual dilution in the GI tract (Syukri 
et al., 2018).   
 
Stability study 
The results of stability studies to optimize 
ibuprofen-loaded SNEDDS formulations C1 and C2 
(Table VI). One-way ANOVA showed that no 
significant difference (p<0.05) the droplet size 
during storage for 4-week. Both preparations are 
physically stable, and there are no apparent 
changes in physical appearance, including the 
droplet size and clarity, during the 4-week storage 
at a higher temperature (40ᵒC±2ᵒC) and relative 
humidity (75±5%). It is then clear that stable 
preparations are found in the ibuprofen-loaded 
SNEDDS formulations with Propylene glycol 
monocaprylate, Polysorbate 20 and PEG 400 as the 
oil, surfactant and co-surfactant at a ratio of 1: 8: 1 
(C1) and 1: 7: 2 (C2). 
 
CONCLUSION 
Ibuprofen was prepared in SNEDDS 
formulation with Propylene glycol monocaprylate, 
Polysorbate 20, and PEG 400 as the oil, surfactant, 
and co-surfactant, respectively. Nine compositions 
with the concentration of Propylene glycol 
monocaprylate (1-3mL), Polysorbate 20 (4-8mL), 
and PEG 400 (1-3mL) were the optimal formulation 
to form a nanoemulsion. The formulation with the 
ratio of 1: 8: 1 and 1: 7: 2 of Propylene glycol 
monocaprylate, Polysorbate 20 and PEG 400 were 
selected compositions after the study of 
thermodynamic stability, robustness to dilution, 
and accelerated stability. These evaluations 
showed the droplet size between 10.50±0.40-
13.43±2.06nm after dilution and 12.00±2.60-
19.67±1.53nm after accelerated stability studies.  
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